Orthofix International | OFIX - Assets


Orthofix International reported $832.61M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AngioDynamics USD 285.41M 6.14M Feb/2025
AtriCure USD 635.44M 26.59M Sep/2025
Dexcom USD 7.5B 173M Sep/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.03B 439.9M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 90.97B 708M Jun/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 832.61M 4.55M Sep/2025
Plus Therapeutics USD 11.39M 1.89M Dec/2023
Smith & Nephew USD 10.69B 150M Dec/2025
STAAR Surgical USD 456.36M 18.58M Sep/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Tandem Diabetes Care USD 874.65M 1.08M Sep/2025
Teleflex USD 7.87B 496.72M Sep/2025
Veracyte USD 1.37B 23.68M Sep/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025